Loading...
TELA Bio Inc is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks significant positive catalysts, has weak financial performance, and no clear technical or trading signals to support a buy decision. While the pre-market price is slightly above the pivot level, the bearish moving averages and lack of momentum suggest caution. Hold for now and monitor for better entry points or stronger signals.
The MACD is positive and expanding, indicating slight bullish momentum. However, the RSI is neutral at 53.693, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The pre-market price of 0.8179 is above the pivot level (0.781) but below the first resistance level (0.866), suggesting limited upward momentum.

MACD shows slight bullish momentum.
Net income dropped by -17.06% YoY, EPS fell by -54.76% YoY, and gross margin declined slightly. No significant trading trends from hedge funds or insiders. No recent news or congress trading data. Bearish moving averages indicate weak price momentum.
In Q3 2025, revenue increased by 9.14% YoY to $20.69M. However, net income dropped by -17.06% YoY to -$8.6M, EPS fell by -54.76% YoY to -0.19, and gross margin decreased slightly to 67.52%. Overall, financial performance shows weak profitability and declining margins.
No data available for analyst ratings or price target changes.